BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yanaga K, Tzakis AG, Shimada M, Campbell WE, Marsh JW, Stieber AC, Makowka L, Todo S, Gordon RD, Iwatsuki S. Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg. 1989;210:180-183. [PMID: 2667473 DOI: 10.1097/00000658-198908000-00007] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Goulis J, Chau TN, Jordan S, Mehta AB, Watkinson A, Rolles K, Burroughs AK. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut. 1999;44:754-758. [PMID: 10205219 DOI: 10.1136/gut.44.5.754] [Cited by in Crossref: 101] [Cited by in F6Publishing: 87] [Article Influence: 4.6] [Reference Citation Analysis]
2 Aref S, Ibrahem L, El Menshawy N, Bassam A. Effect of splenectomy on platelets associated antibodies in hepatitis C patients with thrombocytopenia. Hematology 2012;17:118-21. [PMID: 22664051 DOI: 10.1179/102453312X13221316477705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Tutar N, Isiklar I, Ulu EK, Haberal M. Spleen Size Changes in Pediatric Liver Transplant Recipients With Functioning Grafts. Transplantation Proceedings 2007;39:3199-201. [DOI: 10.1016/j.transproceed.2007.08.105] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
4 DuBois B, Mobley D, Chick JFB, Srinivasa RN, Wilcox C, Weintraub J. Efficacy and safety of partial splenic embolization for hypersplenism in pre- and post-liver transplant patients: A 16-year comparative analysis. Clin Imaging. 2019;54:71-77. [PMID: 30553121 DOI: 10.1016/j.clinimag.2018.11.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
5 Rajalingam R, Javed A, Sharma D, Sakhuja P, Singh S, Nag HH, Agarwal AK. Management of hypersplenism in non-cirrhotic portal hypertension: a surgical series. Hepatobiliary & Pancreatic Diseases International 2012;11:165-71. [DOI: 10.1016/s1499-3872(12)60143-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
6 Ghalib R, Levine C, Hassan M, McClelland T, Goss J, Stribling R, Seu P, Patt YZ. Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis. Hepatology. 2003;37:1165-1171. [PMID: 12717398 DOI: 10.1053/jhep.2003.50160] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
7 Mandell MS, Groves BM. PULMONARY HYPERTENSION IN CHRONIC LIVER DISEASE. Clinics in Chest Medicine 1996;17:17-33. [DOI: 10.1016/s0272-5231(05)70296-3] [Cited by in Crossref: 104] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
8 Lawrence SP, Lezotte DC, Durham JD, Kumpe DA, Everson GT, Bilir BM. Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS): A retrospective analysis. Digest Dis Sci 1995;40:1575-80. [DOI: 10.1007/bf02285211] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
9 Nishizaki T, Hiroshige S, Ikegami T, Uchiyama H, Hashimoto K, Soejima Y, Shimada M. Living-donor liver transplantation for fulminant hepatic failure in adult patients with a left-lobe graft. Surgery. 2002;131:S182-S189. [PMID: 11821808 DOI: 10.1067/msy.2002.119574] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
10 Senzolo M, Burra P, Cholongitas E, Burroughs AK. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol 2006;12:7725-36. [PMID: 17203512 DOI: 10.3748/wjg.v12.i48.7725] [Cited by in CrossRef: 109] [Cited by in F6Publishing: 80] [Article Influence: 7.8] [Reference Citation Analysis]
11 Ando H, Nagino M, Arai T, Nishio H, Nimura Y. Changes in splenic volume during liver regeneration. World J Surg 2004;28:977-81. [PMID: 15573251 DOI: 10.1007/s00268-004-7435-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
12 Hirata Y, Sanada Y, Urahashi T, Ihara Y, Yamada N, Okada N, Tashiro M, Katano T, Otomo S, Ushijima K. Relationship Between Graft Liver Function and the Change of Graft Liver and Spleen Volumes After Technical Variant Liver Transplantation. Transplant Proc. 2016;48:1105-1109. [PMID: 27320567 DOI: 10.1016/j.transproceed.2015.12.089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ishizone S, Makuuchi M, Kawasaki S, Matsunami H, Terada M, Kitahara S, Kamada N, Nakahata T, Kawarasaki H, Iwanaka T. Effect of granulocyte colony-stimulating factor on neutropenia in liver transplant recipients with hypersplenism. J Pediatr Surg 1994;29:510-3. [PMID: 7516966 DOI: 10.1016/0022-3468(94)90079-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
14 Karasu Z, Tekin F, Ersoz G, Gunsar F, Batur Y, Ilter T, Akarca US. Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C. Dig Dis Sci. 2007;52:1535-1539. [PMID: 17464564 DOI: 10.1007/s10620-006-9144-y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
15 Maheshwari A, Mishra R, Thuluvath PJ. Post-liver-transplant anemia: etiology and management. Liver Transpl. 2004;10:165-173. [PMID: 14762852 DOI: 10.1002/lt.20031] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
16 Bolognesi M, Merkel C, Sacerdoti D, Nava V, Gatta A. Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis. 2002;34:144-150. [PMID: 11926560 DOI: 10.1016/s1590-8658(02)80246-8] [Cited by in Crossref: 140] [Cited by in F6Publishing: 42] [Article Influence: 7.4] [Reference Citation Analysis]
17 Pozzato C, Marzano L, Larghi A, Uslenghi E, Quagliuolo M. Splenomegaly and hypersplenism in cirrhotic patients before and after orthotopic liver transplantation. European Journal of Ultrasound 1997;6:43-7. [DOI: 10.1016/s0929-8266(97)00025-6] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
18 Sezai S, Kamisaka K, Ikegami F, Usuki K, Urabe A, Tahara T, Kato T, Miyazaki H. Regulation of hepatic thrombopoietin production by portal hemodynamics in liver cirrhosis. Am J Gastroenterol. 1998;93:80-82. [PMID: 9448180 DOI: 10.1111/j.1572-0241.1998.080_c.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
19 Chikamori F, Nishida S, Selvaggi G, Tryphonopoulos P, Moon JI, Levi DM, Kato T, Island ER, Maki A, Tekin A. Effect of liver transplantation on spleen size, collateral veins, and platelet counts. World J Surg. 2010;34:320-326. [PMID: 20012612 DOI: 10.1007/s00268-009-0314-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
20 Pradella P, Bonetto S, Turchetto S, Uxa L, Comar C, Zorat F, De Angelis V, Pozzato G. Platelet production and destruction in liver cirrhosis. J Hepatol. 2011;54:894-900. [PMID: 21145808 DOI: 10.1016/j.jhep.2010.08.018] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
21 Sekiguchi T, Nagamine T, Takagi H, Mori M. Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C. World J Gastroenterol 2006;12:1205-10. [PMID: 16534872 DOI: 10.3748/wjg.v12.i8.1205] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
22 Ishigami M, Ishizu Y, Onishi Y, Kamei H, Kiuchi T, Itoh A, Hirooka Y, Katano Y, Goto H. Long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiology. Springerplus 2013;2:374. [PMID: 24010032 DOI: 10.1186/2193-1801-2-374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Schiødt FV, Bondesen S, Müller K, Rasmussen A, Hjortrup A, Kirkegaard P, Hansen BA, Tygstrup N, Ott P. Reconstitution of the actin-scavenger system after orthotopic liver transplantation for end-stage liver disease: A prospective and longitudinal study. Liver Transpl 1999;5:310-7. [DOI: 10.1002/lt.500050420] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
24 Dogan GM, Dogan SM, Okut G, Karakas S, Kutluturk K, Ulubaba HE, Sahin TT, Sigirci A, Kutlu R, Yilmaz S. Comprehensive Analysis of Long-term Splenic Volume Changes in Pediatric Liver Transplant Patients: Does It Correlate With Adverse Graft Outcomes? Transplant Proc 2021;53:104-10. [PMID: 32919802 DOI: 10.1016/j.transproceed.2020.08.031] [Reference Citation Analysis]
25 Ikegami T, Toshima T, Takeishi K, Soejima Y, Kawanaka H, Yoshizumi T, Taketomi A, Maehara Y. Bloodless splenectomy during liver transplantation for terminal liver diseases with portal hypertension. J Am Coll Surg. 2009;208:e1-e4. [PMID: 19228523 DOI: 10.1016/j.jamcollsurg.2008.10.034] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
26 Coelho JCU, Balbinot P, Nitsche R, Pinto KA, Parolin MB, Ivantes CAP. Change in platelet count in patients with hypersplenism subjected to liver transplantation. Arq Gastroenterol 2011;48:175-8. [DOI: 10.1590/s0004-28032011000300004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
27 Carlis LD, Favero ED, Rondinara G, Belli LS, Sansalone CV, Zani B, Cazzulani A, Brambilla G, Rampoldi A, Belli L. The role of spontaneous portosystemic shunts in the course of orthotopic liver transplantation. Transplant Int 1992;5:9-14. [DOI: 10.1111/j.1432-2277.1992.tb01715.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
28 Faeh M, Hauser SP, Nydegger UE. Transient thrombopoietin peak after liver transplantation for end-stage liver disease. Br J Haematol. 2001;112:493-498. [PMID: 11167853 DOI: 10.1046/j.1365-2141.2001.02567.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
29 Peck-Radosavljevic M. Hypersplenism. Eur J Gastroenterol Hepatol 2001;13:317-23. [PMID: 11338057 DOI: 10.1097/00042737-200104000-00004] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 3.4] [Reference Citation Analysis]
30 Chatzipetrou MA, Tsaroucha AK, Weppler D, Pappas PA, Kenyon NS, Nery JR, Khan MF, Kato T, Pinna AD, O'Brien C, Viciana A, Ricordi C, Tzakis AG. Thrombocytopenia after liver transplantation. Transplantation. 1999;67:702-706. [PMID: 10096525 DOI: 10.1097/00007890-199903150-00010] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
31 Jabbour N, Zajko A, Orons P, Irish W, Fung JJ, Selby RR. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? Dig Dis Sci. 1998;43:2459-2462. [PMID: 9824134 DOI: 10.1023/a:1026634215918] [Cited by in Crossref: 36] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
32 Dou J, Lou Y, Wu J, Lu Y, Jin Y. Thrombocytopenia in patients with hepatitis B virus-related chronic hepatitis: evaluation of the immature platelet fraction. Platelets. 2014;25:399-404. [PMID: 24047408 DOI: 10.3109/09537104.2013.832742] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
33 Karasu Z, Gurakar A, Kerwin B, Hulagu S, Jazzar A, McFadden R, Nour B, Sebastian A, Cassidy F, Stokes K, Van Thiel DH, Wright H. Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Dig Dis Sci. 2000;45:1971-1976. [PMID: 11117569 DOI: 10.1023/a:1005694617983] [Cited by in Crossref: 28] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
34 Roberts LN, Patel RK, Arya R. Haemostasis and thrombosis in liver disease. British Journal of Haematology 2010;148:507-21. [DOI: 10.1111/j.1365-2141.2009.08021.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 54] [Article Influence: 6.5] [Reference Citation Analysis]
35 Kawano F, Ishizaki Y, Yoshimoto J, Fujiwara N, Kawasaki S. Factors Affecting Persistent Splenomegaly After Adult-to-Adult Living Donor Liver Transplantation Using a Left Lobe. Transplant Proc. 2019;51:1946-1949. [PMID: 31279408 DOI: 10.1016/j.transproceed.2019.02.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Peck-radosavljevic M, Wichlas M, Zacherl J, Stiegler G, Stohlawetz P, Fuchsjäger M, Kreil A, Metz-schimmerl S, Panzer S, Steininger R, Mühlbacher F, Ferenci P, Pidlich J, Gangl A. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood 2000;95:795-801. [DOI: 10.1182/blood.v95.3.795.003k25_795_801] [Cited by in Crossref: 135] [Article Influence: 6.4] [Reference Citation Analysis]
37 Peck-Radosavljevic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Längle F, Steininger R, Mühlbacher F, Gangl A. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver. J Hepatol. 1997;27:127-131. [PMID: 9252085 DOI: 10.1016/s0168-8278(97)80291-7] [Cited by in Crossref: 116] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
38 Chang JH, Choi JY, Woo HY, Kwon JH, You CR, Bae SH, Yoon SK, Choi MG, Chung IS, Kim DG. Severe thrombocytopenia before liver transplantation is associated with delayed recovery of thrombocytopenia regardless of donor type. World J Gastroenterol 2008;14:5723-9. [PMID: 18837091 DOI: 10.3748/wjg.14.5723] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
39 Ikegami T, Shirabe K, Nakagawara H, Yoshizumi T, Toshima T, Soejima Y, Uchiyama H, Yamashita Y, Harimoto N, Maehara Y. Obstructing Spontaneous Major Shunt Vessels is Mandatory to Keep Adequate Portal Inflow in Living-Donor Liver Transplantation. Transplantation 2013;95:1270-7. [DOI: 10.1097/tp.0b013e318288cadc] [Cited by in Crossref: 35] [Cited by in F6Publishing: 5] [Article Influence: 4.4] [Reference Citation Analysis]
40 Egami S, Sugawara Y, Mizuta K, Kaneko J, Kawarasaki H, Makuuchi M. Effect of pediatric living-donor liver transplantation on splenomegaly1: . Transplantation 2002;74:1639-42. [DOI: 10.1097/00007890-200212150-00026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
41 Stiegler G, Stohlawetz P, Peck-Radosavljevic M, Jilma B, Pidlich J, Wichlas M, Höcker P, Panzer S. Direct evidence for an increase in thrombopoiesis after liver transplantation. Eur J Clin Invest 1998;28:755-9. [PMID: 9767375 DOI: 10.1046/j.1365-2362.1998.00348.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
42 Kujovich JL. Hemostatic defects in end stage liver disease. Crit Care Clin. 2005;21:563-587. [PMID: 15992673 DOI: 10.1016/j.ccc.2005.03.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
43 Ben Hamida C, Lauzet JY, Rézaiguia-Delclaux S, Duvoux C, Cherqui D, Duvaldestin P, Stéphan F. Effect of severe thrombocytopenia on patient outcome after liver transplantation. Intensive Care Med 2003;29:756-62. [PMID: 12677370 DOI: 10.1007/s00134-003-1727-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
44 Kisaoglu A, Dandin O, Demiryilmaz I, Dinc B, Adanir H, Yilmaz VT, Aydinli B. A Single-Center Experience in Portal Flow Augmentation in Liver Transplantation With Prior Large Spontaneous Splenorenal Shunt. Transplant Proc 2021;53:54-64. [PMID: 32605772 DOI: 10.1016/j.transproceed.2020.05.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Blankensteijn JD, Schalm SW, Terpstra OT. New aspects of heterotopic liver transplantation. Transplant Int 1992;5:43-50. [DOI: 10.1007/bf00337189] [Cited by in Crossref: 19] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
46 Borel Rinkes IH, Van Der Hoop AG, Hesselink EJ, Metselaar H, De Rave S, Zonderland HM, Schalm SW, Terpstra OT. Does auxiliary heterotopic liver transplantation reverse hypersplenism and portal hypertension? Gastroenterology 1991;100:1126-8. [DOI: 10.1016/0016-5085(91)90293-t] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
47 Barritt AS 4th, Fried MW, Hayashi PH. Persistent portosystemic shunts after liver transplantation causing episodic hepatic encephalopathy. Dig Dis Sci 2010;55:1794-8. [PMID: 19655248 DOI: 10.1007/s10620-009-0901-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
48 Bolognesi M, Sacerdoti D, Bombonato G, Angeli P, Gerunda G, Merenda R, Volpin R, Iemmolo R, Gatta A. Splenic impedance indices: A useful method to monitor patients after liver transplantation? Hepatology 1998;27:674-8. [DOI: 10.1002/hep.510270306] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
49 Gemery JM, Forauer AR, Silas AM, Hoffer EK. Hypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process. BMC Hematol 2016;16:3. [PMID: 26865982 DOI: 10.1186/s12878-016-0042-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
50 Gangireddy VG, Kanneganti PC, Sridhar S, Talla S, Coleman T. Management of thrombocytopenia in advanced liver disease. Can J Gastroenterol Hepatol. 2014;28:558-564. [PMID: 25222481 DOI: 10.1155/2014/532191] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
51 Schöffski P, Tacke F, Trautwein C, Martin MU, Caselitz M, Hecker H, Manns MP, Ganser A. Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease. Liver. 2002;22:114-120. [PMID: 12028404 DOI: 10.1034/j.1600-0676.2002.01547.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]